Budget Amount *help |
¥4,940,000 (Direct Cost: ¥3,800,000、Indirect Cost: ¥1,140,000)
Fiscal Year 2016: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2015: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2014: ¥2,080,000 (Direct Cost: ¥1,600,000、Indirect Cost: ¥480,000)
|
Outline of Final Research Achievements |
Clarithromycin(CAM) has 2 crystal forms at ambient temperature and meta-stable crystal(FormⅠ) transforms to stable crystal(FormⅡ) and hydrate(FormⅣ) immediately by contact with water. By using this property, we succeeded in development of highly --loaded CAM sustained release formulation with 0-order manner and gastro-floating formulation. FormⅡ can be obtained by dispersion in water-filtration-drying processes or heat treatment(150℃). Since these treatment lead to increase API cost, we tried and establish the transformation of FormⅠto FromⅡ during the manufacturing process of CAM formulation.
|